Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;110:3329-3334
Published online before print November 15, 2004, doi: 10.1161/01.CIR.0000147828.86593.85
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
110/21/3329    most recent
01.CIR.0000147828.86593.85v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kashiwakura, Y.
Right arrow Articles by Daida, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kashiwakura, Y.
Right arrow Articles by Daida, H.
Related Collections
Right arrow Lipids
Right arrow Apoptosis
Right arrow Cell biology/structural biology
Right arrow Other Vascular biology

(Circulation. 2004;110:3329-3334.)
© 2004 American Heart Association, Inc.


Molecular Cardiology

Dynamin-2 Regulates Oxidized Low-Density Lipoprotein–Induced Apoptosis of Vascular Smooth Muscle Cell

Yuji Kashiwakura, MD, PhD; Masami Watanabe, MD, PhD; Norihiro Kusumi, MD; Katsuhiko Sumiyoshi, PhD; Yasutomo Nasu, MD, PhD; Hiroshi Yamada, PhD; Tatsuya Sawamura, MD, PhD; Hiromi Kumon, MD, PhD; Kohji Takei, PhD; Hiroyuki Daida, MD, PhD

From the Department of Cardiology, Juntendo University School of Medicine, Tokyo (Y.K., K.S., H.D.); Departments of Urology (M.W., N.K., Y.N., H.K.) and Neuroscience (H.Y., K.T.), Okayama University Graduate School of Medicine and Dentistry, Okayama; and National Cardiovascular Center Research Institute, Osaka (T.S.), Japan.

Correspondence to Yuji Kashiwakura, MD, PhD, Department of Cardiology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan. E-mail yu-kashi{at}med.juntendo.ac.jp

Received March 23, 2004; de novo received May 15, 2004; revision received June 30, 2004; accepted July 6, 2004.

Background— On exposure to oxidized low-density lipoprotein (oxLDL), vascular cells generally undergo apoptosis, which is one of the major pathogenic factors of atherosclerosis. In this study, we examined the role of dynamin (a crucial GTPase protein in endocytosis) in oxLDL-induced apoptosis of vascular smooth muscle cells (VSMC).

Methods and Results— After oxLDL stimulation, dynamin-2 colocalized with LOX-1 around the cell surface, as well as oxLDL in the cytoplasm, suggesting that dynamin-2 was involved in scavenger receptor–mediated oxLDL endocytosis. Downregulation of dynamin-2 induced by dynamin-2 dominant negative plasmid (K44A) resulted in a decrease of oxLDL uptake and thereby in a reduction of apoptosis. These data demonstrated that dynamin-2 was involved in oxLDL-induced apoptosis via the oxLDL endocytotic pathway. On the other hand, dynamin-2 wild-type plasmid transfection promoted oxLDL-induced apoptosis without increasing oxLDL uptake. Interestingly, the p53 inhibitor pifithrin-{alpha} (PFT) significantly reduced apoptosis promoted by wild-type dynamin-2 (78% reduction compared with the PFT[–] condition). These results indicated that dynamin-2 enhanced oxLDL-induced apoptosis of VSMC by participating in the p53 pathway, probably as a signal transducer. Moreover, we demonstrated that, in advanced plaques of apolipoprotein E–/– mice, dynamin-2 expression was often enhanced in apoptotic VSMC, suggesting that dynamin-2 might participate in apoptosis of VSMC even in vivo.

Conclusions— Our data demonstrated that dynamin-2 at least partially regulated oxLDL-induced apoptosis of VSMC by participating in 2 independent pathways: the oxLDL endocytotic pathway and the p53 pathway. These findings suggest that dynamin-2 may serve as a new research or therapeutic target in vascular disease.


Key Words: apoptosis • atherosclerosis • lipoproteins • cells, muscle, smooth




This article has been cited by other articles:


Home page
FASEB J.Home page
S. Mosig, K. Rennert, S. Krause, J. Kzhyshkowska, K. Neunubel, R. Heller, and H. Funke
Different functions of monocyte subsets in familial hypercholesterolemia: potential function of CD14+CD16+ monocytes in detoxification of oxidized LDL
FASEB J, March 1, 2009; 23(3): 866 - 874.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
K. J. Kelly, P. Wu, C. E. Patterson, C. Temm, and J. H. Dominguez
LOX-1 and inflammation: a new mechanism for renal injury in obesity and diabetes
Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1136 - F1145.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
B. Sun, B. B. Boyanovsky, M. A. Connelly, P. Shridas, D. R. van der Westhuyzen, and N. R. Webb
Distinct mechanisms for OxLDL uptake and cellular trafficking by class B scavenger receptors CD36 and SR-BI
J. Lipid Res., December 1, 2007; 48(12): 2560 - 2570.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Dandapat, C. Hu, L. Sun, and J. L. Mehta
Small Concentrations of oxLDL Induce Capillary Tube Formation From Endothelial Cells via LOX-1 Dependent Redox-Sensitive Pathway
Arterioscler Thromb Vasc Biol, November 1, 2007; 27(11): 2435 - 2442.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X.-F. Wang, M. Birringer, L.-F. Dong, P. Veprek, P. Low, E. Swettenham, M. Stantic, L.-H. Yuan, R. Zobalova, K. Wu, et al.
A Peptide Conjugate of Vitamin E Succinate Targets Breast Cancer Cells with High ErbB2 Expression
Cancer Res., April 1, 2007; 67(7): 3337 - 3344.
[Abstract] [Full Text] [PDF]